Source:http://linkedlifedata.com/resource/pubmed/id/21204901
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2011-2-8
|
pubmed:abstractText |
Prolonged antiretroviral treatment (ART) significantly changes the cytokine secretion capacities of HIV-1-specific T cells. However, it is unclear whether these changes result from decreased viremia or they correspond to true functional recovery of viral-specific immune response. To study this issue, we analysed the quantitative and qualitative differences of HIV-1-specific and polyclonal CD4+ and CD8+ T cells between 26 naive and 52 treated individuals. HIV-1 Gag and staphylococcal enterotoxin B (SEB)-reactive T cells were determined by flowcytometric intracellular secretion of IFN-? or/and ?L-2. ART resulted in increase of single IL-2 and decrease of single IFN-?-secreting HIV-1 CD4+ T cells, while both cytokines secreting HIV-1 CD4+ T cells were presented in comparable frequencies in both groups. Viral loads correlated negatively with single IL-2 and positively with single IFN-?-secreting HIV-1 CD4+ cells. Single IL-2 HIV-1 CD4+ T cells correlated positively with both cytokines secreting polyclonal CD8+ T cells. By qualitative analysis, a dominant IL-2 HIV-1 CD4+ T cell response (> 70% single IL-2) was identified only in ART suppressed patients, who also generated increased dual specific polyclonal CD8+ T cells. Polyfunctional HIV-1 CD4+ T cell responses were detected even in naive individuals with high viremia. In conclusion, the presence of dominant IL-2 HIV-1 CD4+ T cell response, associated with increased CD8+ T cells capable to produce IL-2, indicates that the recovery of HIV-1-specific CD4+ T cell functionality under ART is a feasible goal. Furthermore, polyfunctional HIV-1 CD4+ T cell responses seem not to be directly involved in viral replication control.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1365-3083
|
pubmed:author | |
pubmed:copyrightInfo |
© 2011 The Authors. Scandinavian Journal of Immunology © 2011 Blackwell Publishing Ltd.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
256-65
|
pubmed:meshHeading |
pubmed-meshheading:21204901-Adult,
pubmed-meshheading:21204901-Aged,
pubmed-meshheading:21204901-Anti-Retroviral Agents,
pubmed-meshheading:21204901-CD4-Positive T-Lymphocytes,
pubmed-meshheading:21204901-CD8-Positive T-Lymphocytes,
pubmed-meshheading:21204901-Cell Separation,
pubmed-meshheading:21204901-Female,
pubmed-meshheading:21204901-Flow Cytometry,
pubmed-meshheading:21204901-HIV Infections,
pubmed-meshheading:21204901-HIV-1,
pubmed-meshheading:21204901-Humans,
pubmed-meshheading:21204901-Interleukin-2,
pubmed-meshheading:21204901-Male,
pubmed-meshheading:21204901-Middle Aged,
pubmed-meshheading:21204901-gag Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2011
|
pubmed:articleTitle |
Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
|
pubmed:affiliation |
Immunology Department, General Hospital Athens "LAIKO", Athens, Greece. tsalimalma@hotmail.com
|
pubmed:publicationType |
Journal Article
|